These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 21409844)

  • 21. Japanese Cedar Pollen-Specific IgA in Nasal Secretions and Nasal Allergy Symptoms.
    Suzuki M; Yokota M; Ozaki S; Matsumoto T; Nakamura Y
    Ann Otol Rhinol Laryngol; 2019 Apr; 128(4):330-337. PubMed ID: 30678469
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of human T cell epitopes in Japanese cypress pollen allergen, Cha o 1, elucidates the intrinsic mechanism of cross-allergenicity between Cha o 1 and Cry j 1, the major allergen of Japanese cedar pollen, at the T cell level.
    Sone T; Dairiki K; Morikubo K; Shimizu K; Tsunoo H; Mori T; Kino K
    Clin Exp Allergy; 2005 May; 35(5):664-71. PubMed ID: 15898991
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of co-existing seasonal allergic rhinitis caused by Japanese Cedar Pollinosis (SAR-JCP) upon asthma control status.
    Hojo M; Ohta K; Iikura M; Hirashima J; Sugiyama H; Takahashi K
    Allergol Int; 2015 Apr; 64(2):150-5. PubMed ID: 25838090
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Specific IgE to Japanese cypress (Chamaecyparis obtusa) in patients with nasal allergy.
    Ito H; Nishimura J; Suzuki M; Mamiya S; Sato K; Takagi I; Baba S
    Ann Allergy Asthma Immunol; 1995 Apr; 74(4):299-303. PubMed ID: 7719888
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Seasonal changes in antigen-specific T-helper clone sizes in patients with Japanese cedar pollinosis: a 2-year study.
    Horiguchi S; Tanaka Y; Uchida T; Chazono H; Ookawa T; Sakurai D; Okamoto Y
    Clin Exp Allergy; 2008 Mar; 38(3):405-12. PubMed ID: 18070160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Exposure to Cypress Pollens and Subsequent Symptoms: A Panel Study.
    Rakotozandry T; Cassagne E; Martin S; Alauzet P; Navarro I; Delcroux C; Caillaud D; Besancenot JP; Thibaudon M; Charpin D
    Int Arch Allergy Immunol; 2019; 180(2):135-141. PubMed ID: 31390631
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cedar and cypress pollen counts are associated with the prevalence of allergic diseases in Japanese schoolchildren.
    Yoshida K; Adachi Y; Akashi M; Itazawa T; Murakami Y; Odajima H; Ohya Y; Akasawa A
    Allergy; 2013 Jun; 68(6):757-63. PubMed ID: 23621581
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Present situation of cedar pollinosis in Japan and its immune responses.
    Okamoto Y; Horiguchi S; Yamamoto H; Yonekura S; Hanazawa T
    Allergol Int; 2009 Jun; 58(2):155-62. PubMed ID: 19307773
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recognition of T cell epitopes unique to Cha o 2, the major allergen in Japanese cypress pollen, in allergic patients cross-reactive to Japanese cedar and Japanese cypress pollen.
    Sone T; Dairiki K; Morikubo K; Shimizu K; Tsunoo H; Mori T; Kino K
    Allergol Int; 2009 Jun; 58(2):237-45. PubMed ID: 19307778
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Severity assessment of Japanese cedar pollinosis using the practical guideline for the management of allergic rhinitis in Japan and the allergic rhinitis and its impact on asthma guideline.
    Gotoh M; Yuta A; Okano M; Ohta N; Matsubara A; Okubo K
    Allergol Int; 2013 Jun; 62(2):181-9. PubMed ID: 23435559
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prevalence of Japanese cedar pollinosis among schoolchildren in Japan.
    Ozasa K; Dejima K; Takenaka H
    Int Arch Allergy Immunol; 2002 Jun; 128(2):165-7. PubMed ID: 12065917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The effect of initial treatment by FP aqueous nasal spray in patients with Japanese cedar pollinosis].
    Nakabayashi S; Suzuki N; Nakatsuka S; Ikeda K; Takasaka T; Inamura N
    Nihon Jibiinkoka Gakkai Kaiho; 1996 Sep; 99(9):1162-71. PubMed ID: 8914412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determining minimal clinically important differences in Japanese cedar/cypress pollinosis patients.
    Higaki T; Okano M; Kariya S; Fujiwara T; Haruna T; Hirai H; Murai A; Gotoh M; Okubo K; Yonekura S; Okamoto Y; Nishizaki K
    Allergol Int; 2013 Dec; 62(4):487-93. PubMed ID: 24153331
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The effect of fluticasone propionate topically dosed prior to the pollen scattering season on cellular infiltration into the surface of nasal mucous membrane in patients with Japanese cedar pollinosis].
    Onishi M; Suihou X; Okubo K; Ikeda M; Yokoshima K; Okuda M
    Arerugi; 1993 Mar; 42(3 Pt 1):228-35. PubMed ID: 8498894
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Early interventional treatment with intranasal mometasone furoate in Japanese cedar/cypress pollinosis: a randomized placebo-controlled trial.
    Makihara S; Okano M; Fujiwara T; Kimura M; Higaki T; Haruna T; Noda Y; Kanai K; Kariya S; Nishizaki K
    Allergol Int; 2012 Jun; 61(2):295-304. PubMed ID: 22441634
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epidemiology of cypress pollen allergy in Montpellier.
    Caimmi D; Raschetti R; Pons P; Dhivert-Donnadieu H; Bousquet PJ; Bousquet J; Demoly P
    J Investig Allergol Clin Immunol; 2012; 22(4):280-5. PubMed ID: 22812197
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Desloratadine for the treatment of cypress pollen-induced allergic rhinitis.
    Demoly P; Dreyfus I; Dhivert-Donnadieu H; Mesbah K
    Ann Allergy Asthma Immunol; 2009 Sep; 103(3):260-6. PubMed ID: 19788025
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CYPRESS POLLEN SESITIZATION IN GEORGIA: CLINICAL AND MOLECULAR CHARACTERISTICS.
    Abramidze T; Gotua M; Bochorishvili E; Melikidze N; Gamkrelidze A
    Georgian Med News; 2021 Jan; (310):101-107. PubMed ID: 33658417
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Investigation of the sensitization rate for gibberellin-regulated protein in patients with Japanese cedar pollinosis.
    Mori Y; Okazaki F; Momma K; Narita H; Kondo Y
    Allergol Immunopathol (Madr); 2022; 50(2):89-92. PubMed ID: 35257550
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Antigen specific sublingual immunotherapy for pediatric Japanese cedar pollinosis].
    Yuta A; Miyamoto Y; Ogihara H; Hattori R; Okubo K
    Arerugi; 2009 Feb; 58(2):124-32. PubMed ID: 19329875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.